![(EMS LOGO)](https://capedge.com/proxy/8-K/0000950123-06-001191/y17172y1717202.jpg)
Contact: | Deborah Hileman Vice President Communications/Investor Relations (888) 213-5667 Deborah.hileman@emsc.net |
EMERGENCY MEDICAL SERVICES ANNOUNCES RESULTS FOR THE FOURTH QUARTER AND 11 MONTHS ENDED DECEMBER 31, 2005
Highlights:
• | Net revenue increased 13.4% for the fourth quarter compared with the same quarter last year and 11.1% for the 11 months ended December 31, 2005, compared with the same period last year; |
• | EBITDA increased 18.4% for the fourth quarter compared with the same quarter last year and 16.4% for the 11 months ended December 31, 2005, compared with the same period last year; |
• | Diluted earnings per share were $0.17 for the fourth quarter and $0.55 for the 11 months ended December 31, 2005. |
Greenwood Village, Colorado (February 6, 2006)– Emergency Medical Services Corporation (NYSE: EMS) (“EMSC” or the “Company”) today announced results for the fourth quarter and 11 months ended December 31, 2005. EMSC was formed in connection with the combined acquisition of American Medical Response, Inc. (AMR) and EmCare Holdings Inc. (EmCare) from Laidlaw International, Inc. (Laidlaw) in February 2005 by affiliates of Onex Corporation (Onex) and members of AMR/EmCare management. The Company completed its initial public offering on December 21, 2005, issuing 8.1 million shares at $14 per share for total gross proceeds of $113.4 million. The primary use of proceeds from this offering was to repay indebtedness under the Company’s senior secured credit facility.
“We are pleased with the Company’s strong performance during 2005. It was a year of significant change that included the acquisition of AMR and EmCare, a debt offering in connection with the acquisition, the consolidation of the support functions of the Company, and our equity offering in December. In the midst of these changes, the Company continued to improve its financial performance, grow its core business, enter new markets and responded to one of the most devastating natural disasters in our nation’s history,” said William A. Sanger, chairman and chief executive officer.
EMS Announces Fourth Quarter and Year-End Results
Page 2
February 6, 2006
Page 2
February 6, 2006
Mr. Sanger continued, “I want to thank the employees of American Medical Response and the physicians of EmCare who responded without hesitation to meet the needs of the citizens of the Gulf Coast area after hurricanes Katrina and Rita. Their dedication to caring for people in need truly exemplified our Company’s ‘mission’ throughout this unprecedented natural disaster.”
Results of Operations for the Fourth Quarter 2005
For the fourth quarter ended December 31, 2005, EMSC generated net revenue of $467.8 million, an increase of 13.4% (11.4% excluding additional hurricane deployment revenue) compared with the same quarter last year. For the fourth quarter ended December 31, 2005, EMSC generated EBITDA of $39.8 million (including a $1.8 million restructuring charge), an increase of 18.4% compared with the same quarter last year.
EMSC had net income of $6.1 million, or $0.17 per diluted share, on 35.8 million weighted shares outstanding, for the fourth quarter of 2005, compared with net income of $12.3 million for the same period last year. The net income variance is primarily due to an increase in interest and amortization expense in 2005 incurred in connection with the acquisition from Laidlaw.
AMR generated net revenue of $298.0 million, an increase of 10.8% (7.7% excluding additional hurricane deployment revenue) compared with the same quarter last year. AMR generated EBITDA of $27.2 million, an increase of 9.8% (excluding $1.6 million of the restructuring charge related to AMR), compared with the same quarter last year. The improvement in EBITDA was primarily from revenue growth and continued improvements in AMR’s insurance and support cost structure.
EmCare generated net revenue of $169.8 million, an increase of 18.3% compared with the same quarter last year. EmCare generated EBITDA of $14.2 million, an increase of 61.0%, compared with the same quarter last year. The increase in EBITDA was primarily from revenue increases in existing contracts, from new contracts, and from leveraging the fixed cost component of provider compensation plans.
Cash flows from operating activities for the fourth quarter ended December 31, 2005, were $4.4 million, compared with $24.9 million for the same quarter last year. This variance is primarily due to an increase in receivables from the additional hurricane deployment and additional interest expense incurred in the acquisition from Laidlaw. Capital expenditures were $14.0 million for the fourth quarter of 2005, compared with $8.7 million for the same quarter last year. Other investing activities provided a source of funds of $18.9 million for the fourth quarter of 2005, compared with a $9.8 million use of funds for the same quarter last year.
EMS Announces Fourth Quarter and Year-End Results
Page 3
February 6, 2006
Page 3
February 6, 2006
Results of Operations for the 11 Months Ended December 31, 2005
For the 11-month period from the effective date of the acquisition from Laidlaw to December 31, 2005, the Company generated net revenue of $1.655 billion, an increase of 11.1% (10.2% excluding additional hurricane deployment revenue) compared with the same period last year. For the 11 months ended December 31, 2005, EMSC generated EBITDA of $137.5 million, an increase of 16.4% compared with the same period last year.
EMSC had net income of $20.1 million, or $0.55 per diluted share, on 34.3 million weighted shares outstanding, for the 11-month period, compared with net income of $36.8 million for the same period last year. The variance was primarily due to an increase in interest and amortization expense in 2005 incurred in connection with the acquisition from Laidlaw.
AMR generated net revenue of $1.06 billion, an increase of 8.8% (7.5% excluding additional hurricane deployment) compared with the same period last year. AMR generated EBITDA of $93.4 million, an increase of 10.1% compared with the same 11-month period last year. The improvement in EBITDA was primarily from revenue growth and continued improvements in AMR’s insurance and support cost structure.
EmCare generated net revenue of $595.8 million, an increase of 15.4% compared with the same period last year. EmCare generated EBITDA of $44.1 million, an increase of 32.4% compared with the same period last year. The increase in EBITDA was primarily from revenue increases in existing contracts, from new contracts, and from leveraging the fixed cost component of provider compensation plans.
Cash flows from operating activities for the 11 months ended December 31, 2005, were $112.8 million, compared with $124.9 million for the same period last year. This variance is primarily due to an increase in receivables from the additional hurricane deployment and additional interest expense incurred in the acquisition from Laidlaw. Capital expenditures were $48.9 million for the 11-month period ended December 31, 2005, compared with $38.9 million for the same period last year. Cash used in other non-acquisition related investing activities was $34.8 million for the 11-month period in 2005, compared with $53.6 million for the same period last year.
The Company reduced its senior secured credit facility by $99.1 million in December 2005 using proceeds from the initial public offering and had no borrowings outstanding under its revolving credit facility at December 31, 2005.
Guidance
The Company expects diluted EPS to be in the range of $0.75 to $0.78 and EBITDA to be in the range of $156.0 million to $160.0 million for the year ended December 31, 2006.
The Company expects diluted EPS to be in the range of $0.75 to $0.78 and EBITDA to be in the range of $156.0 million to $160.0 million for the year ended December 31, 2006.
EMS Announces Fourth Quarter and Year-End Results
Page 4
February 6, 2006
Page 4
February 6, 2006
Conference Call
EMSC management will host a conference call and live webcast on February 7, 2006, at 11:00 a.m. EST to discuss the Company’s financial results. A 30-day online replay will be available approximately one hour following the conclusion of the live broadcast. A link to the live broadcast and online replay is available on the Investor Relations section of the Company’s website atwww.emsc.net.
EMSC management will host a conference call and live webcast on February 7, 2006, at 11:00 a.m. EST to discuss the Company’s financial results. A 30-day online replay will be available approximately one hour following the conclusion of the live broadcast. A link to the live broadcast and online replay is available on the Investor Relations section of the Company’s website atwww.emsc.net.
About Emergency Medical Services Corporation
Under the recognized brands of EmCare and American Medical Response (AMR), Emergency Medical Services Corporation, headquartered in Greenwood Village, Colorado, is a leading provider of emergency medical services in the United States, serving more than nine million patients each year. EmCare provides outsourced emergency department staffing and management services to more than 300 hospitals nationwide. American Medical Response is America’s leading provider of ambulance services with local operations in 35 states. For more information, visit www.emsc.net.
Under the recognized brands of EmCare and American Medical Response (AMR), Emergency Medical Services Corporation, headquartered in Greenwood Village, Colorado, is a leading provider of emergency medical services in the United States, serving more than nine million patients each year. EmCare provides outsourced emergency department staffing and management services to more than 300 hospitals nationwide. American Medical Response is America’s leading provider of ambulance services with local operations in 35 states. For more information, visit www.emsc.net.
Forward-Looking Statements
Certain statements and information in this press release may be deemed to be “forward-looking statements” within the meaning of the Federal Private Securities Litigation Reform Act of 1995. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, and all statements (other than statements of historical facts) that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future are forward-looking statements. These statements are often characterized by terminology such as “believe,” “hope,” “may,” “anticipate,” “should,” “intend,” “plan,” “will,” “expect,” “estimate,” “project,” “positioned,” “strategy” and similar expressions, and are based on assumptions and assessments made by EMSC management in light of their experience and their perception of historical trends, current conditions, expected future developments, and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and EMSC undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments and business decisions to differ materially from forward-looking statements are described in EMSC’s filings with the SEC from time to time, including the section entitled “Risk Factors” in the most recent Registration Statement on Form S-1.
Certain statements and information in this press release may be deemed to be “forward-looking statements” within the meaning of the Federal Private Securities Litigation Reform Act of 1995. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, and all statements (other than statements of historical facts) that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future are forward-looking statements. These statements are often characterized by terminology such as “believe,” “hope,” “may,” “anticipate,” “should,” “intend,” “plan,” “will,” “expect,” “estimate,” “project,” “positioned,” “strategy” and similar expressions, and are based on assumptions and assessments made by EMSC management in light of their experience and their perception of historical trends, current conditions, expected future developments, and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and EMSC undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments and business decisions to differ materially from forward-looking statements are described in EMSC’s filings with the SEC from time to time, including the section entitled “Risk Factors” in the most recent Registration Statement on Form S-1.
EMS Announces Fourth Quarter and Year-End Results
Page 5
February 6, 2006
Page 5
February 6, 2006
Comparability of Historical Financial Data
The comparability of our financial information has been affected by a number of significant events and transactions. Effective as of January 31, 2005, AMR and EmCare were acquired by Emergency Medical Services L.P. (“EMS LP”) and in connection with the acquisition we changed our fiscal year-end to December 31 from August 31. For all periods prior to the acquisition, the AMR and EmCare businesses formerly owned by Laidlaw are referred to as the “Predecessor.” In addition, EMSC completed an IPO and used net proceeds from this offering to pay down a portion of a senior secured credit facility entered into as part of the acquisition.
The comparability of our financial information has been affected by a number of significant events and transactions. Effective as of January 31, 2005, AMR and EmCare were acquired by Emergency Medical Services L.P. (“EMS LP”) and in connection with the acquisition we changed our fiscal year-end to December 31 from August 31. For all periods prior to the acquisition, the AMR and EmCare businesses formerly owned by Laidlaw are referred to as the “Predecessor.” In addition, EMSC completed an IPO and used net proceeds from this offering to pay down a portion of a senior secured credit facility entered into as part of the acquisition.
Non-GAAP Financial Measures Reconciliation
This news release includes presentations of EBITDA, which is defined as operating income plus depreciation and amortization expense. EBITDA is commonly used by management and investors as a measure of leverage capacity, debt service ability and liquidity.
This news release includes presentations of EBITDA, which is defined as operating income plus depreciation and amortization expense. EBITDA is commonly used by management and investors as a measure of leverage capacity, debt service ability and liquidity.
EBITDA is not considered a measure of financial performance under U.S. generally accepted accounting principles (“GAAP”), and the items excluded from EBITDA are significant components in understanding and assessing our financial performance. EBITDA should not be considered in isolation or as an alternative to such GAAP measures as net income, cash flows provided by or used in operating, investing or financing activities or other financial statement data presented in our consolidated financial statements as an indicator of financial performance or liquidity. Reconciliations of non-GAAP financial measures are provided in this news release.
Since EBITDA is not a measure determined in accordance with GAAP and is susceptible to varying calculations, EBITDA, as presented, may not be comparable to other similarly titled measures of other companies.
EMS Announces Fourth Quarter and Year-End Results
Page 6
February 6, 2006
Page 6
February 6, 2006
EMERGENCY MEDICAL SERVICES CORPORATION
Unaudited Condensed Statements of Operations and Supplemental Information
Including a Reconciliation of EBITDA to Net Income
(in thousands, except per share data and supplemental information)
Unaudited Condensed Statements of Operations and Supplemental Information
Including a Reconciliation of EBITDA to Net Income
(in thousands, except per share data and supplemental information)
Predecessor | Predecessor | |||||||||||||||
Consolidated | Combined | Consolidated | Combined | |||||||||||||
Three Months | Three Months | 11 Months | 11 Months | |||||||||||||
ended | ended | ended | ended | |||||||||||||
December 31, 2005 | December 31, 2004 | December 31, 2005 | December 31, 2004 | |||||||||||||
Net revenue | $ | 467,832 | $ | 412,452 | $ | 1,655,485 | $ | 1,490,201 | ||||||||
Compensation and benefits | 323,460 | 283,049 | 1,146,055 | 1,034,287 | ||||||||||||
Operating expenses | 64,387 | 56,660 | 233,087 | 204,184 | ||||||||||||
Insurance expense | 22,418 | 22,737 | 82,800 | 74,411 | ||||||||||||
Selling, general and administrative expenses | 16,014 | 16,405 | 54,262 | 57,770 | ||||||||||||
Restructuring charges | 1,781 | — | 1,781 | 1,381 | ||||||||||||
EBITDA | 39,772 | 33,601 | 137,500 | 118,168 | ||||||||||||
Reconciliation of EBITDA to net income | ||||||||||||||||
EBITDA | 39,772 | 33,601 | 137,500 | 118,168 | ||||||||||||
Depreciation and amortization expense | (15,332 | ) | (10,966 | ) | (54,143 | ) | (45,593 | ) | ||||||||
Income from operations | 24,440 | 22,635 | 83,357 | 72,575 | ||||||||||||
Interest expense | (13,406 | ) | (3,284 | ) | (47,813 | ) | (11,963 | ) | ||||||||
Realized gain (loss) on investments | (124 | ) | 236 | (164 | ) | (955 | ) | |||||||||
Interest and other income | 851 | 518 | 1,040 | 728 | ||||||||||||
Loss on early debt extinguishment | (2,040 | ) | — | (2,040 | ) | — | ||||||||||
Income tax expense | (3,715 | ) | (7,840 | ) | (14,372 | ) | (23,550 | ) | ||||||||
Equity in earnings of unconsolidated subsidiary | 59 | — | 59 | — | ||||||||||||
Net income | $ | 6,065 | $ | 12,265 | $ | 20,067 | $ | 36,835 | ||||||||
Net income per common share: | ||||||||||||||||
Basic | $ | 0.17 | $ | 0.56 | (1) | |||||||||||
Diluted | $ | 0.17 | $ | 0.55 | (1) | |||||||||||
Average common shares outstanding: | ||||||||||||||||
Basic | 34,807,051 | 33,622,057 | ||||||||||||||
Dilutive | 35,803,966 | 34,282,691 | ||||||||||||||
Supplemental information | ||||||||||||||||
EmCare Patient visits | 1,520,109 | 1,349,155 | 5,579,955 | 4,929,913 | ||||||||||||
AMR ambulance transports | 721,638 | 689,522 | 2,644,685 | 2,596,808 | ||||||||||||
AMR revenue weighted transports | 735,463 | 707,055 | 2,701,342 | 2,664,567 |
(1) | Net income available to shareholders used in calculating net income per share for the 11 months ended December 31, 2005 has been reduced by $1.2 million related to accretion of put rights, or $.04 per share, that existed for certain shareholders during a portion of the 11-month period. The put right expired upon completion of the initial public offering. |
EMS Announces Fourth Quarter and Year-End Results
Page 7
February 6, 2006
Page 7
February 6, 2006
EMERGENCY MEDICAL SERVICES CORPORATION
Reconciliation of Segment EBITDA to Income from Operations
Reconciliation of Segment EBITDA to Income from Operations
Predecessor | Predecessor | |||||||||||||||
Consolidated | Combined | Consolidated | Combined | |||||||||||||
Three Months | Three Months | 11 months | 11 Months | |||||||||||||
ended | ended | ended | ended | |||||||||||||
December 31, 2005 | December 31, 2004 | December 31, 2005 | December 31, 2004 | |||||||||||||
AMR | �� | |||||||||||||||
EBITDA | $ | 25,591 | $ | 24,793 | $ | 93,404 | $ | 84,851 | ||||||||
Depreciation and amortization | (12,563 | ) | (9,757 | ) | (44,090 | ) | (38,348 | ) | ||||||||
Income from operations | 13,028 | 15,036 | 49,314 | 46,503 | ||||||||||||
EmCare | ||||||||||||||||
EBITDA | 14,181 | 8,808 | 44,096 | 33,317 | ||||||||||||
Depreciation and amortization | (2,747 | ) | (1,209 | ) | (10,031 | ) | (7,245 | ) | ||||||||
Income from operations | 11,434 | 7,599 | 34,065 | 26,072 | ||||||||||||
Total | ||||||||||||||||
EBITDA | 39,772 | 33,601 | 137,500 | 118,168 | ||||||||||||
Depreciation and amortization | (15,310 | ) | (10,966 | ) | (54,121 | ) | (45,593 | ) | ||||||||
Depreciation and amortization parent | (22 | ) | — | (22 | ) | — | ||||||||||
Income from operations | $ | 24,440 | $ | 22,635 | $ | 83,357 | $ | 72,575 | ||||||||
EMERGENCY MEDICAL SERVICES CORPORATION
Unaudited Condensed Balance Sheets
(in thousands)
Unaudited Condensed Balance Sheets
(in thousands)
Predecessor | ||||||||
Consolidated | Combined | |||||||
December 31, 2005 | January 31, 2005 | |||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 18,048 | $ | 14,631 | ||||
Trade and other accounts receivable, net | 411,184 | 369,767 | ||||||
Other current assets | 86,064 | 136,045 | ||||||
Total current assets | 515,296 | 520,443 | ||||||
Non-current assets: | ||||||||
Property, plant and equipment, net | 138,036 | 128,766 | ||||||
Goodwill and other intangible assets, net | 329,351 | 16,075 | ||||||
Other long-term assets | 284,345 | 318,226 | ||||||
Total assets | $ | 1,267,028 | $ | 983,510 | ||||
LIABILITIES AND EQUITY | ||||||||
Current liabilities | $ | 277,435 | $ | 233,309 | ||||
Long-term debt | 495,520 | 5,651 | ||||||
Other long-term liabilities | 149,089 | 146,273 | ||||||
Total liabilities | 922,044 | 385,233 | ||||||
Total equity | 344,984 | 598,277 | ||||||
Total liabilities and equity | $ | 1,267,028 | $ | 983,510 | ||||
EMERGENCY MEDICAL SERVICES CORPORATION
Unaudited Condensed Statements of Cash Flows
(in thousands)
Unaudited Condensed Statements of Cash Flows
(in thousands)
Predecessor | Predecessor | |||||||||||||||
Consolidated | Combined | Consolidated | Combined | |||||||||||||
Three Months | Three Months | 11 Months | 11 Months | |||||||||||||
ended | ended | ended | ended | |||||||||||||
December 31, 2005 | December 31, 2004 | December 31, 2005 | December 31, 2004 | |||||||||||||
Cash Flows from Operating Activities | $ | 4,359 | $ | 24,890 | $ | 112,821 | $ | 124,851 | ||||||||
Cash Flows from Investing Activities | 4,935 | (18,549 | ) | (912,487 | ) | (92,459 | ) | |||||||||
Cash Flows from Financing Activities | (1,359 | ) | (18,686 | ) | 803,083 | (39,385 | ) | |||||||||
Change in cash and cash equivalents | 7,935 | (12,345 | ) | 3,417 | (6,993 | ) | ||||||||||
Cash and cash equivalents, beginning of period | 10,113 | 16,208 | 14,631 | 10,856 | ||||||||||||
Cash and cash equivalents, end of period | $ | 18,048 | $ | 3,863 | $ | 18,048 | $ | 3,863 | ||||||||